Emisphere is a specialty pharmaceutical company that has recently commenced commercial operations. The Company launched its first prescription product, oral Eligen B , in the U.S. in March . Beyond Eligen B , the Company utilizes its proprietary Eligen Technology to create new oral formulations of therapeutic agents. Emisphere is currently partnered with global pharmaceutical companies for the development of new orally delivered therapeutics. For more information, please visit www.emisphere.com.
Quote | Emisphere Technologies, Inc. (OTCMKTS:EMIS)
Last: | $7.81 |
---|---|
Change Percent: | 0.13% |
Open: | $7.8 |
Close: | $7.81 |
High: | $7.82 |
Low: | $7.8 |
Volume: | 184,515 |
Last Trade Date Time: | 12/08/2020 04:54:51 pm |
News | Emisphere Technologies, Inc. (OTCMKTS:EMIS)
Summers Value Partners is a boutique value manager that uses a focused, long-term approach to investing in areas of the market where most managers are unwilling or unable to participate. The Summers Value Fund LP gained 14.7% net in 2020, which compares against the Russell 2000 Index ...
ROSELAND, N.J., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (“Emisphere” or the “Company”) today announced the completion of the previously announced transaction whereby Novo Nordisk A/S (“Novo Nordisk”) (NYSE: NVO) acquired ...
Message Board Posts | Emisphere Technologies, Inc. (OTCMKTS:EMIS)
Subject | By | Source | When |
---|---|---|---|
EMIS: effective immediately, "Emisphere Technologies, Inc. (EMIS) completed | Renee | investorshub | 12/09/2020 2:14:15 PM |
Agreed 100%. If they did all they | Stockfun1 | investorshub | 02/04/2020 3:22:54 AM |
For maximum share price appreciation, $EMIS must | DEVJ | investorshub | 02/03/2020 5:12:17 PM |
FYI:: The news that has caused the | Stockfun1 | investorshub | 01/31/2020 1:26:04 AM |
I've been put for a while. Took my | catty | investorshub | 01/29/2020 10:28:08 PM |
News, Short Squeeze, Breakout and More Instantly...
Emisphere Technologies, Inc. Company Name:
EMIS Stock Symbol:
OTCMKTS Market:
ROSELAND, N.J., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (“Emisphere” or the “Company”) today announced the completion of the previously announced transaction whereby Novo Nordisk A/S (“Novo Nordisk”) (NYSE: NVO) acquired ...
Labaton Sucharow, a nationally ranked shareholder rights firm, is investigating potential securities violations and breach of fiduciary duty claims against pharmaceutical company Emisphere Technologies, Inc. (OTC Ticker: EMIS). If you currently own shares of Emisphere and want to re...
ROSELAND, N.J., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (“Emisphere” or the “Company”) today announced that it has entered into a definitive agreement with Novo Nordisk A/S (“Novo Nordisk”), whereby Novo Nordisk will acquire E...